Bank of America
IMGN

Bank of America’s Immunogen Inc IMGN Stock Holding History

Bank of America’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-780,279
Closed -$23.1M – 8374
2023
Q4 		$23.1M Buy
780,279
+238,477
+44% +$4.75M ﹤0.01% 2011
2023
Q3 		$8.6M Buy
541,802
+127,624
+31% +$2.12M ﹤0.01% 2864
2023
Q2 		$7.82M Sell
414,178
-1,454,845
-78% -$17.2M ﹤0.01% 2959
2023
Q1 		$7.18M Buy
1,869,023
+214,149
+13% +$913K ﹤0.01% 3159
2022
Q4 		$8.21M Buy
1,654,874
+468,537
+39% +$2.54M ﹤0.01% 2883
2022
Q3 		$5.67M Sell
1,186,337
-318,912
-21% -$1.68M ﹤0.01% 3212
2022
Q2 		$6.77M Buy
1,505,249
+44,817
+3% +$195K ﹤0.01% 3072
2022
Q1 		$6.95M Buy
1,460,432
+376,567
+35% +$2.08M ﹤0.01% 3271
2021
Q4 		$8.04M Buy
1,083,865
+325,868
+43% +$2.03M ﹤0.01% 3170
2021
Q3 		$4.3M Buy
757,997
+4,413
+0.6% +$25.5K ﹤0.01% 3711
2021
Q2 		$4.97M Sell
753,584
-25,567
-3% -$178K ﹤0.01% 3508
2021
Q1 		$6.31M Sell
779,151
-33,854
-4% -$276K ﹤0.01% 3170
2020
Q4 		$5.24M Sell
813,005
-67,273
-8% -$392K ﹤0.01% 3084
2020
Q3 		$3.17M Sell
880,278
-51,107
-5% -$206K ﹤0.01% 3326
2020
Q2 		$4.29M Sell
931,385
-89,101
-9% -$379K ﹤0.01% 2972
2020
Q1 		$3.48M Sell
1,020,486
-73,999
-7% -$324K ﹤0.01% 3019
2019
Q4 		$5.59M Sell
1,094,485
-104,755
-9% -$356K ﹤0.01% 3132
2019
Q3 		$2.9M Buy
1,199,240
+33,395
+3% +$88.7K ﹤0.01% 3721
2019
Q2 		$2.53M Sell
1,165,845
-704,545
-38% -$1.67M ﹤0.01% 3851
2019
Q1 		$5.07M Buy
1,870,390
+1,075,483
+135% +$4.66M ﹤0.01% 3152
2018
Q4 		$3.82M Sell
794,907
-33,008
-4% -$200K ﹤0.01% 3274
2018
Q3 		$7.84M Sell
827,915
-385,306
-32% -$3.7M ﹤0.01% 2732
2018
Q2 		$11.8M Buy
1,213,221
+216,420
+22% +$2.28M ﹤0.01% 2295
2018
Q1 		$10.5M Sell
996,801
-27,243
-3% -$269K ﹤0.01% 2365
2017
Q4 		$6.56M Sell
1,024,044
-714,717
-41% -$4.41M ﹤0.01% 2875
2017
Q3 		$13.3M Buy
1,738,761
+582,760
+50% +$3.87M ﹤0.01% 2226
2017
Q2 		$8.22M Sell
1,156,001
-183,517
-14% -$840K ﹤0.01% 2560
2017
Q1 		$5.18M Buy
1,339,518
+127,695
+11% +$373K ﹤0.01% 2988
2016
Q4 		$2.47M Sell
1,211,823
-177,520
-13% -$356K ﹤0.01% 3594
2016
Q3 		$3.72M Buy
1,389,343
+94,729
+7% +$275K ﹤0.01% 3104
2016
Q2 		$3.99M Buy
1,294,614
+242,841
+23% +$1.52M ﹤0.01% 2996
2016
Q1 		$8.96M Buy
1,051,773
+66,394
+7% +$562K ﹤0.01% 2247
2015
Q4 		$13.4M Buy
985,379
+20,285
+2% +$250K ﹤0.01% 1991
2015
Q3 		$9.27M Buy
965,094
+892,318
+1,226% +$13M ﹤0.01% 2292
2015
Q2 		$1.05M Buy
72,776
+50,647
+229% +$556K ﹤0.01% 4071
2015
Q1 		$199K Sell
22,129
-5,794
-21% -$42K ﹤0.01% 4928
2014
Q4 		$171K Sell
27,923
-148,096
-84% -$1.35M ﹤0.01% 5482
2014
Q3 		$1.86M Buy
176,019
+138,957
+375% +$1.57M ﹤0.01% 3447
2014
Q2 		$440K Buy
37,062
+28,576
+337% +$359K ﹤0.01% 4755
2014
Q1 		$126K Sell
8,486
-492
-5% -$7.76K ﹤0.01% 5793
2013
Q4 		$132K Sell
8,978
-4,169
-32% -$64.1K ﹤0.01% 5925
2013
Q3 		$224K Sell
13,147
-18,291
-58% -$322K ﹤0.01% 5360
2013
Q2 		$521K Buy
+31,438
New +$509K ﹤0.01% 4703

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of America's IMGN Position: Q1 2024 in Review

Bank of America sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 780,279 shares — an estimated $23.1M sold.

Bank of America first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $23.1M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Bank of America reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 780,279 Immunogen Inc shares in Q1 2024, an estimated $23.1M.
  • Bank of America first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Bank of America's Immunogen Inc position peaked at $23.1M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.